Skip to search.
 All Ordinaries Up 0.35%

More On BIT.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Biotron Ltd (BIT.AX)

-ASX
0.14 Down 0.01(6.67%) 27 Feb 15:42
Add to Portfolio
Prev Close:0.15
Open:0.16
Bid:0.14
Ask:0.14
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.14 - 0.16
52wk Range:0.07 - 0.30
Volume:2,102,295
Avg Vol (3m):727,632
Market Cap:31.96M
P/E (ttm):N/A
EPS (ttm):-0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biotron Limited develops and commercializes novel small molecule antiviral therapeutics targeting Hepatitis C virus (HCV) and HIV-1 in Australia. Its lead drug includes the BIT225, a viroporin inhibitor, which is in Phase 2 clinical trials used fo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback